NOTE: Facebook and Twitter continue to suppress our reach day after day, week after week, and so on. We appreciate your visit, but we ask you to add our free newsletter to your email. You might not see us in the newsfeeds, but you will see us in your inbox fighting back against the enemy. Sign up on the right side of the page or where you see our newsletter signup box. Thank you!
Baby steps in the beginning, and hopefully a complete preventative vaccine to come.
Dr. Fauci says early results of Gilead's coronavirus drug trial shows significant positive effect, suggests "a drug can block this virus" pic.twitter.com/kBnkAo76el [1]
— Bloomberg Originals (@bbgoriginals) April 29, 2020 [2]
For those questioning the legitimacy of the 5 days vs 10 day trial (no placebo), read Gilead’s (GILD) second press release about the NIH trial. It hit its primary endpoint – that means there is a statistical benefit over placebo. In this context, the 5 days vs 10 day takes on more meaning. NIH study confirms the drug works, and the Gilead study shows you can treat 5 days instead of 10, theoretically allowing treatment of twice as many patients with the same amount of drug.
Good for GILD finally pushing what the FDA won’t acknowledge. Gild is the only single stock that could move the market 2,000 points higher instantly
via Reuters
Fauci, though, told reporters during a White House meeting with Trump that the data on the drug, remdesivir, needs to be further analyzed.
Some trial data for the drug will likely be announced later on Wednesday at a White House task force briefing, according to the National Institute of Allergy and Infectious Diseases.
Gilead on Wednesday said remdesivir helped improve outcomes for patients with COVID-19 in a clinical trial, and provided data suggesting it worked better when given earlier in the course of illness caused by the virus. The closely watched drug has moved markets in the past few weeks following release of partial information on several studies that painted a mixed picture of its effectiveness.
Former U.S. Food and Drug Administration chief Scott Gottlieb said on Twitter there was now enough data to support authorizing the drug for emergency use.
Fauci told reporters the data shows the drug had benefit in reducing the time to recover from the virus. While the data still must be peer-reviewed, he said it is opening the door to the possibility of a treatment.
There are currently no approved treatments or vaccines for the highly contagious novel coronavirus, but many approaches are being tried while awaiting an effective vaccine to prevent infection by the virus.
This piece was written by Wayne Dupree on April 29, 2020. It originally appeared in WayneDupree.com [3] and is used by permission.
Read more at WayneDupree.com:
[VIDEO] Stunning Backstage Footage During DNC 2016 Convention When Hillary Thought She’d Already Won the WH [4]
[VIDEO] Trump-Hater Chrissy Teigen Mocked for Posting Desperate Bathroom “Swimsuit” Video [5]
Report: Fox Nation Allegedly Severs Ties With Diamond And Silk [6]